StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Insmed (INSM) PT Lowered to $205 at RBC Capital
May 8, 2026 7:32 AM
RBC Capital analyst Leonid Timashev ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
BofA Securities Reiterates Buy Rating on Insmed (INSM); 'pullback overdone'
May 12, 2026 12:02 PM